Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,127.20
(
0.47%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
98.74
(
-1.90%
)
Bitcoin
74,205.54
(
0.36%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122793
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 96906

Wednesday, 07/28/2010 6:18:10 AM

Wednesday, July 28, 2010 6:18:10 AM

Post# of 257253
FDA grants priority review for Merck KGaA’s Cladribine in RRMS:

http://www.reuters.com/article/idCNN2720940320100727

The PDUFA date is on or about 12/5/10 (Merck KGaA is not disclosing the exact date).

A decision on Cladribine from the EMA is expected in 3Q10. The MAA was submitted in Jul 2009 (#msg-39836037).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Where Real Traders Talk Markets

Join thousands of traders sharing insights, catalysts, and charts.

Join Today